CHRS
Coherus Oncology, Inc. · Healthcare
Director Mats Wahlstrom sold $1.5M of Coherus Oncology, Inc.
Sold$1,474,677
$27.52Price
53,583Shares
−8%Stake
What CHRS did after the filing
Prices for CHRS after this filing aren't in yet.
Traded Wed, Dec 7. Filed Fri, Dec 9, 11:05 AM ET, during the session. Not investment advice.